Individual holder
DEAN NICHOLAS M
US·4 granted patents·2 pending applications·8 citations·filing 2009–2019
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
6 records- 0183US8252762B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2009·Granted Aug 28, 2012·5 cites·25 claims
- 0276US9096851B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2012·Granted Aug 4, 2015·2 cites·51 claims
- 0365US9173894B2Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)DEAN NICHOLAS M·Filed 2012·Granted Nov 3, 2015·1 cites·27 claims
- 0464US2020190521A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)DEAN NICHOLAS M·Filed 2019·Application pending·0 cites
- 0559US8772260B2Methods for inhibiting expression of connective tissue growth factorDEAN NICHOLAS M·Filed 2012·Granted Jul 8, 2014·0 cites·27 claims
- 0638US2011213011A1Modulation of smad3 expressionDEAN NICHOLAS M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DEAN NICHOLAS M files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →